alnuctamab
bms
['mmsm', 'multiple myeloma', 'alnuctamab', 'cc-93269', 'bms']
alnuctamab (alnuc; bms-986349; cc-93269), a b-cell maturation antigen (bcma) x cd3 t-cell engager (tce), in patients (pts) with relapsed/refractory multiple myeloma (rrmm): results from a phase 1 first-in-human clinical study #ash22 #mmsm #myeloma 
Hematology is in my ??. Posts are mine. Mayo Clinic Associate, Asst Prof, BMT RNCC, RN Navigator, emeritus. IMF NLB. MM KOL. Patient educator & advocate.